Northumbria Healthcare NHS Foundation Trust, North Shields, NE29 8NH, UK.
Antimicrob Resist Infect Control. 2013 Jan 14;2(1):2. doi: 10.1186/2047-2994-2-2.
In November 2004, a national target was set for the English hospital trusts to reduce the Meticillin-Resistant Staphylococcus aureus (MRSA) bacteremia rate by 60% by April 2008 against the number during 2003/04 (baseline year). In our organisation the number of MRSA bacteremias had risen since 2002 and peaked at 75 in 2005/06. A target was set to reduce the number and series of specific and non- specific interventions was introduced including universal MRSA screening. This study analyzes the impact of universal MRSA screening using a quasi-experimental design using routinely gathered data.
This study used data gathered routinely for clinical governance, quality control, financial management and outbreak monitoring purposes. Interrupted Time Series (ITS) analysis of 15 pre- and 19 post- universal MRSA screening (and decolonisation) quarterly numbers of bacteremias was carried out where Meticillin-Sensitive Staphylococcus aureus (MSSA) numbers served as non-equivalent dependent variable (control).
An immediate sharp fall in MRSA bacteremias was observed following the universal MRSA screening (and decolonisation) commenced in Q2, 2007. The number dropped sharply from 23 (Q2, 2007) to 10 (Q3, 2007) for all MRSA bacteremias, and, from 15 (Q2, 2007) to 6 (Q3, 2007) for bacteremias ≥48 hours of hospitalization. The declining trend continued reaching zero in Q2, 2009 and Q4, 2010 for those with ≥48 hours of hospitalization and all bacteremias, respectively. ITS analysis revealed significant impact of universal MRSA screening on all MRSA bacteremias (β2 -0.554, p 0.000) and those with ≥48 of hospitalization (β2 -0.577, p 0.001). Impact estimation predicted 17 and 13 bacteremias for all and those with ≥48 hours hospitalization, respectively in the 19th quarter post-intervention, if the intervention did not occur. The number of MRSA isolates from non-blood culture systemic sources as percentage of admissions also dropped significantly from 3.32% in Q2, 2007 to 1.51% in Q3, 2007 (β2 -0.506, p 0.000) which is still running low at 0.33% at the end of Q1, 2012. On the other hand, there was no statistically significant impact of universal screening on MSSA bacteremias.
We conclude that of all interventions, the universal MRSA screening (and decolonisation) is the most effective intervention associated with significant and sharp drop in MRSA burden.
2004 年 11 月,英国国家医疗服务体系(NHS)设定了一个目标,要求 2008 年 4 月所有医院信托机构的耐甲氧西林金黄色葡萄球菌(MRSA)菌血症发病率比 2003/04 年(基线年)降低 60%。在我们的机构中,自 2002 年以来,MRSA 菌血症的数量一直在上升,并在 2005/06 年达到 75 例的峰值。设定了一个目标,以减少数量和一系列具体和非具体的干预措施,包括普遍的 MRSA 筛查。本研究使用常规收集的数据,采用准实验设计分析了普遍 MRSA 筛查的影响。
本研究使用了为临床治理、质量控制、财务管理和暴发监测目的而常规收集的数据。对 15 个预先和 19 个普遍 MRSA 筛查(和去定植)后的每季度菌血症数量进行了中断时间序列(ITS)分析,其中耐甲氧西林金黄色葡萄球菌(MSSA)数量作为非等效的因变量(对照)。
在 2007 年第二季度开始普遍进行 MRSA 筛查(和去定植)后,立即观察到 MRSA 菌血症急剧下降。所有 MRSA 菌血症的数量从 23(2007 年第二季度)急剧下降到 10(2007 年第三季度),住院 48 小时以上的菌血症数量从 15(2007 年第二季度)下降到 6(2007 年第三季度)。下降趋势持续到 2009 年第二季度和 2010 年第四季度,住院 48 小时以上的菌血症和所有菌血症的数量均为零。ITS 分析显示,普遍 MRSA 筛查对所有 MRSA 菌血症(β2 -0.554,p 0.000)和住院 48 小时以上的菌血症(β2 -0.577,p 0.001)均有显著影响。如果没有干预,预计在第 19 个干预季度,所有菌血症和住院 48 小时以上的菌血症将分别发生 17 例和 13 例。从非血培养的全身感染源分离出的 MRSA 分离株的比例也从 2007 年第二季度的 3.32%显著下降到 2007 年第三季度的 1.51%(β2 -0.506,p 0.000),这一比例在 2012 年第一季度末仍保持在 0.33%的低位。另一方面,普遍筛查对 MSSA 菌血症没有统计学上的显著影响。
我们得出结论,在所有干预措施中,普遍的 MRSA 筛查(和去定植)是最有效的干预措施,与 MRSA 负担的显著和急剧下降有关。